Development of potential anticancer agents that target the telomere sequence

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 13, 2010, Pages 3982-3986

  Park, Myunji ^a   Bruice, Thomas C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; Telomerase; Telomere

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; CYANAMIDE; DEOXYRIBONUCLEIC GUANIDINE; DNA; GUANIDINE DERIVATIVE; OLIGONUCLEOTIDE; TELOMERASE; UNCLASSIFIED DRUG;

ARTICLE; BASE MISPAIRING; BINDING COMPETITION; CANCER GENE THERAPY; CONTROLLED STUDY; DNA SEQUENCE; DRUG DNA BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVE SITE; GENE TARGETING; RNA BINDING; TELOMERE;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; DNA; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; GUANIDINES; HUMANS; MOLECULAR STRUCTURE; NUCLEIC ACID CONFORMATION; OLIGODEOXYRIBONUCLEOTIDES; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TELOMERASE; TELOMERE;

EID: 77954310398     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.04.089     Document Type: Article

References (32)

1. H. Yi, and J.N. Jing Acta pharmacol. sin. 26 2005 513
2. E.H. Blackburn Nature 350 1991 569
3. V.L. Makarov, Y. Hirose, and J.P. Langmore Cell 88 1997 657
4. R. McElligott, and R.J. Wellinger EMBO J. 16 1997 3705
5. L.K. White, W.E. Wright, and J.W. Shay Trends Biotechnol. 19 2001 114
6. M. Lei, P. Baumann, and T.R. Cech Biochemistry 41 2002 14560
7. M. Lei, A.J. Zaug, E.R. Podell, and T.R. Cech J. Biol. Chem. 280 2005 20449
8. B.S. Herbert, G.C. Gellert, A. Hochreiter, K. Pongracz, W.E. Wright, D. Zielinska, A.C. Chin, C.B. Harley, J.W. Shay, and S.M. Gryaznov Oncogene 24 2005 5262
9. R.O. Dempcy, K.A. Browne, and T.C. Bruice Proc. Natl. Acad. Sci. U.S.A. 92 1995 6097
10. R.O. Dempcy, K.A. Browne, and T.C. Bruice J. Am. Chem. Soc. 117 1995 6140
11. R.O. Dempcy, O. Almarsson, and T.C. Bruice Proc. Natl. Acad. Sci. U.S.A. 91 1994 7864
12. D.A. Barawkar, Y. Kwok, and T.C. Bruice J. Am. Chem. Soc. 122 2000 5244
13. X. Zhang, and T.C. Bruice Bioorg. Med. Chem. Lett. 18 2008 665
14. E. Uhlmann, and A. Peyman Chem. Rev. 90 1990 544
15. P.D. Cook S.T. Crooks, B. Lebleu, Antisense Research and Applications 1993 CRC Boca Raton, FL 149 187
16. A. De Mesmaeker, R. Haener, P. Martin, and H.E. Moser Acc. Chem. Res. 28 1995 366
17. S. Agrawal, and Q.Y. Zhao Curr. Opin. Chem. Biol. 2 1998 519
18. B.A. Linkletter, I.E. Szabo, and T.C. Bruice Nucleic Acids Res. 29 2001 2370
19. K.A. Browne, R.O. Dempcy, and T.C. Bruice Proc. Natl. Acad. Sci. U.S.A. 92 1995 7051
20. B.A. Linkletter, I.E. Szabo, and T.C. Bruice J. Am. Chem. Soc. 121 1999 3888
21. B.A. Linkletter, I.E. Szabo, and T.C. Bruice Bioorg. Med. Chem. 8 2000 1893
22. D.A. Barawkar, and T.C. Bruice Proc. Natl. Acad. Sci. U.S.A. 95 1998 11047
23. H. Challa, and T.C. Burice Bioorg. Med. Chem. Lett. 11 2001 2423
24. Synthesis of 7: C-Phosphoramidate (50 mg) was added to a solution of compound 6 in DMF at 0 °C and stirred at ice bath (0 °C) for 4 h. The solid was collected by washing with dichloromethane and ether and vacuum dried.
25. P. Job Ann. Chim. 9 1928 113
26. 4 buffer, while the ionic strength (μ) was held constant with 100 mM KCl. The absorbance of each solution at 260 nm (15 °C) was measured with a Cary 100-E2 9802310Z UV/VIS spectrometer. DNA oligomer concentrations were determined spectrophotometrically using extinction coefficients provided by the manufacturer (IDT®). The reported absorbance are an average of three experiments (±0.003)
27. m values are an average of three experiments (±0.2).
28. M.J. Park, J.W. Toporouski, and T.C. Bruice Bioorg. Med. Chem. 14 2006 1743
29. J. Gralla, and D.M. Crothers J. Mol. Biol. 78 1973 301
30. L.A. Marky, and K.J. Breslauer Biopolymers 26 1987 2601
31. K.J. Breslauer S. Agrawal, Methods in Molecular Biology Vol. 26 1995 Humana Totowa 347
32. I.E. Szabo, and T.C. Bruice Bioorg. Med. Chem. 12 2004 4233